India to United States: Pemetrexed Export Trade Route
India has recorded 34 verified shipments of Pemetrexed exported to United States, representing a combined trade value of $3.6M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $107.0K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 56% of total export value with 14 shipments worth $2.0M USD. On the buying side, EUGIA US LLC is the largest importer in United States with $1.5M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, SHILPA MEDICARE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Pemetrexed corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $3.6M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's pemetrexed manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $107.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with pemetrexed's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #1 among India's top pemetrexed export destinations globally.
On the import side, key buyers of Indian pemetrexed in United States include EUGIA US LLC, AMNEAL PHARMACEUTICALS, EUGIA US LLC, and 11 others. EUGIA US LLC is the single largest importer with 9 shipments valued at $1.5M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#1
- Annual growth+28.8%
- Demand growth+25.9%
- Regulatory ease78/100
Top 10 Indian Pemetrexed Exporters to United States
Showing top 10 of 10 Indian suppliers exporting Pemetrexed to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $145.3K per shipment | 14 | $2.0M | 55.9% |
| 2 | SHILPA MEDICARE LIMITED Avg $676.6K per shipment | 2 | $1.4M | 37.2% |
| 3 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $30.8K per shipment | 6 | $184.9K | 5.1% |
| 4 | GLAND PHARMA LIMITED Avg $54.4K per shipment | 1 | $54.4K | 1.5% |
| 5 | INTAS PHARMACEUTICALS LIMITED Avg $1.8K per shipment | 2 | $3.5K | 0.1% |
| 6 | VEA IMPEX (I) PRIVATE LIMITED Avg $1.1K per shipment | 2 | $2.2K | 0.1% |
| 7 | INTAS PHARMACEUTICALS LTD Avg $1.9K per shipment | 1 | $1.9K | 0.1% |
| 8 | KOIT BIOPHARMA PRIVATE LIMITED Avg $836 per shipment | 2 | $1.7K | 0.0% |
| 9 | ATLAS ENTERPRISES Avg $552 per shipment | 3 | $1.7K | 0.0% |
| 10 | MERIT POLYCHEM PVT. LTD. Avg $41 per shipment | 1 | $41 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting pemetrexed to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, SHILPA MEDICARE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, GLAND PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED, VEA IMPEX (I) PRIVATE LIMITED, INTAS PHARMACEUTICALS LTD, KOIT BIOPHARMA PRIVATE LIMITED, ATLAS ENTERPRISES, MERIT POLYCHEM PVT. LTD.. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 14 shipments worth $2.0M USD, giving it a 56% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Pemetrexed Importers in United States
Showing top 10 of 14 known buyers in United States receiving Pemetrexed shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pemetrexed in United States include EUGIA US LLC, AMNEAL PHARMACEUTICALS, EUGIA US LLC,, RXCROSSROADS 3PL LLC, Apotex Inc - Signet, among 14 total buyers. The largest importer is EUGIA US LLC, accounting for $1.5M USD across 9 shipments — representing 42% of all pemetrexed imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA US LLC | 9 | $1.5M | 42.4% |
| 2 | AMNEAL PHARMACEUTICALS | 2 | $1.4M | 37.2% |
| 3 | EUGIA US LLC, | 5 | $492.8K | 13.5% |
| 4 | RXCROSSROADS 3PL LLC | 6 | $184.9K | 5.1% |
| 5 | Apotex Inc - Signet | 1 | $54.4K | 1.5% |
| 6 | XXONTXXE LXXORAXXRIEXX | 2 | $3.5K | 0.1% |
| 7 | TO THE ORDER OF INVOICE RAISED TO | 2 | $2.2K | 0.1% |
| 8 | FRONTAGE LABORATORIES INC | 1 | $1.9K | 0.1% |
| 9 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $1.6K | 0.0% |
| 10 | JORGE HUMBERTO SEPULVEDA | 1 | $928 | 0.0% |
Showing top 10 of 14 Pemetrexed importers in United States on this route.
Top 10 Pemetrexed Formulations Imported by United States
Showing top 10 of 26 product formulations shipped on the India to United States Pemetrexed route, ranked by trade value
United States imports a wide range of pemetrexed formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PEMRYDI RTU (PEMETREXED INJECTION) 100MG/10ML (10MG/ML) BNO. P400043, 45, 47 MFGDT: 02/2024 EXPDT: 01/2026 — accounts for $703.1K USD across 1 shipments. There are 26 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PEMRYDI RTU (PEMETREXED INJECTION) 100MG/10ML (10MG/ML) BNO. P400043, 45, 47 MFGDT: 02/2024 EXPDT: 01/2026 | 1 | $703.1K | 19.3% |
| 2 | PEMRYDI RTU (PEMETREXED INJECTION) 500MG/50ML (10MG/ML) BNO. P400034, 35, 38 MFGDT: 02/2024 EXPDT: 01/2026 | 1 | $650.1K | 17.9% |
| 3 | PEMETREXED INJECTION 100 PEMETREXED FORINJECTION USP 100 MG VIAL SDV BLUEPOINT USA | 2 | $405.1K | 11.1% |
| 4 | PEMETREXED INJECTION 500PEMETREXED FORINJECTION USP 500 MG/VIAL SDV - BLUEPOINT - USA | 1 | $402.4K | 11.1% |
| 5 | PEMETREXED INJECTION 500 PEMETREXED FORINJECTION USP 500 MG VIAL SDV BLUEPOINT USA | 3 | $380.5K | 10.5% |
| 6 | PEMETREXED INJECTION 500 (PEMETREXED FORINJECTION USP 500 MG/VIAL (SDV) - US) | 2 | $251.5K | 6.9% |
| 7 | PEMETREXED INJECTION 100 (PEMETREXED FORINJECTION USP 100 MG/VIAL (SDV) - US) | 2 | $208.3K | 5.7% |
| 8 | PEMETREXED INJECTION 1000 PEMETREXED FOR INJECTION USP 1000 MG/VIAL SDV - US | 1 | $134.0K | 3.7% |
| 9 | PEMETREXED INJECTION 100 PEMETREXED FORINJECTION USP 100 MG/VIAL SDV - BLUEPOINT - USA | 1 | $111.0K | 3.1% |
| 10 | PEMETREXED INJECTION 500 (PEMETREXED FORINJECTION USP 500 MG/VIAL (SDV) - BLUEPOINT - USA) | 1 | $80.2K | 2.2% |
Showing top 10 of 26 Pemetrexed formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 6 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's pemetrexed exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, SHILPA MEDICARE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $107.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pemrydi rtu (pemetrexed injection) 500mg/50ml (10mg/ml) bno. p400034, 35, 38 mfgdt: 02/2024 expdt: 01/2026 and pemetrexed injection 100 pemetrexed forinjection usp 100 mg vial sdv bluepoint usa, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EUGIA US LLC is the largest importer with 9 shipments worth $1.5M USD — representing 42% of all pemetrexed imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.6M
- Avg. Shipment
- $107.0K
- Suppliers
- 10
- Buyers
- 14
- Transit (Sea)
- ~17 days
- Annual Growth
- +28.8%
Related Analysis
Reverse Direction
United States → India — Pemetrexed (Import)Other Pemetrexed Routes
Unlock the Full India to United States Pemetrexed Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 34 shipments on this route.
Frequently Asked Questions — India to United States Pemetrexed Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pemetrexed to United States?
The leading Indian exporters of Pemetrexed to United States are EUGIA PHARMA SPECIALITIES LIMITED, SHILPA MEDICARE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 56% of total trade value on this route.
Q What is the total value of Pemetrexed exports from India to United States?
India exports Pemetrexed to United States worth approximately $3.6M USD across 34 recorded shipments. The average value per shipment is $107.0K USD.
Q Which ports does India use to ship Pemetrexed to United States?
The most active port of origin is HYDERABAD AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 23% by air.
Q How long does shipping take from India to United States for Pemetrexed?
The average transit time for Pemetrexed shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Pemetrexed trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.8% with demand growth tracking at 25.9%. The route is ranked #1 among India's top Pemetrexed export destinations globally.
Q How many suppliers are active on the India to United States Pemetrexed route?
There are currently 10 active Indian suppliers exporting Pemetrexed to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 56% of total shipment value.
Q Who are the main importers of Pemetrexed from India in United States?
The leading importers of Indian Pemetrexed in United States include EUGIA US LLC, AMNEAL PHARMACEUTICALS, EUGIA US LLC,, RXCROSSROADS 3PL LLC, Apotex Inc - Signet. EUGIA US LLC is the largest buyer with 9 shipments worth $1.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Pemetrexed.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 14 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 34 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
34 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists